Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Newlink Genetics Corporation

Clinical trials sponsored by Newlink Genetics Corporation, explained in plain language.

Completed 2 Terminated 1
Sort by
  • Could an immune-boosting pill make melanoma treatments work better?

    Disease control Completed

    This study tested a drug called indoximod, taken as a pill, together with standard immune checkpoint inhibitors (ipilimumab or pembrolizumab) in 131 adults with advanced or metastatic melanoma that could not be removed by surgery. The goal was to see if the combination was safe a…

    Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control

    Last updated Jun 27, 2026 13:00 UTC

  • New combo tackles tough pancreatic cancer

    Disease control Completed

    This study tested an experimental immunotherapy called indoximod added to standard chemotherapy (gemcitabine and nab-paclitaxel) in 157 people with metastatic pancreatic cancer. The goal was to find a safe dose and see if the combination helps people live longer. The trial has co…

    Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control

    Last updated Jun 27, 2026 12:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space